GRM5 and post-traumatic stress disorder: As highlighted throughout this review and illustrated in Figure 1, glutamate dysfunction is a consistent feature observed across drugs of abuse and recent evidence implicates metabotropic glutamate receptor 5 (mGlu5) in the pathophysiology of PTSD and neuroimmune function.